Abstract

IL-1 family members have multiple pleiotropic functions affecting various tissues and cells, including the regulation of the immune response, hematopoietic homeostasis, bone remodeling, neuronal physiology, and synaptic plasticity. Many of these activities are involved in various pathological processes and immunological disorders, including tumor initiation and progression. Indeed, IL-1 family members have been described to contribute to shaping the tumor microenvironment (TME), determining immune evasion and drug resistance, and to sustain tumor aggressiveness and metastasis. This review addresses the role of IL-1 family members in bone sarcomas, particularly the highly metastatic osteosarcoma (OS) and Ewing sarcoma (EWS), and discusses the IL-1-family-related mechanisms that play a role in bone metastasis development. We also consider the therapeutic implications of targeting IL-1 family members, which have been proposed as (i) relevant targets for anti-tumor and anti-metastatic drugs; (ii) immune checkpoints for immune suppression; and (iii) potential antigens for immunotherapy.

MeSH

Cytokines, Sarcoma, Osteosarcoma, Macrophages, Neoplasm Metastasis, Pharmaceutical Preparations, Cells, Neoplasms, Interleukin-1, Tumor Microenvironment

Cited by

• IL-1 Superfamily Across 400+ Species: Therapeutic Targets and Disease Implications. Biology (Basel), 2025
• The Role of Chronic Inflammation in Pediatric Cancer. Cancers (Basel), 2025
• Druggable upregulated proteins in EWS-FLI-driven Ewing sarcoma as emerging new therapeutic targets. Am J Transl Res, 2025